Please login to the form below

Not currently logged in
Email:
Password:

Aurobindo

This page shows the latest Aurobindo news and features for those working in and with pharma, biotech and healthcare.

Francis exits Sandoz, reigniting spinoff rumours

Francis exits Sandoz, reigniting spinoff rumours

It sold Sandoz’s dermatology and generic oral solid products to India’s Aurobindo Pharma, claiming that the move would allow the company to devote its time to high value generics

Latest news

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    radioligands and CAR‐T for cancer. $2.1B. Sale. Aurobindo. NovartIs sold part of Sandoz’s US generics. ... Roche. Oral solid generics and dermatology business. Collaboration. $1.375B. Sandoz/ Aurobindo.

  • Deal Watch January 2017 Deal Watch January 2017

    140. Generis. Aurobindo. Company acquisition. Generic products. 135. Maverick. Takeda. Option to acquire.

  • Pharma deals in July 2015 Pharma deals in July 2015

    In early 2014 Actavis sold most of its European generics business to Aurobindo and in March 2015 completed the acquisition of Allergan.

  • Pharma deals during January 2014 Pharma deals during January 2014

    Slimming the business down a little, Actavis sold some of its generic products in France, Italy, Spain,  Portugal, Belgium, Germany and the Netherlands to Aurobindo for $41m.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Ramprasad Reddy to chair Aurobindo’s US business

    In addition, Aurobindo's board also approved that Ramprasad Reddy relinquish his executive responsibilities as full-time director of the company, although he will continue as non-exectuive director. ... Ramprasad Reddy also has roles at several other

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics